Sedation in the Pediatric Intensive Care Unit: Challenges, Outcomes, and Future Strategies in the United States

Nov 2, 2016 by in PEDIATRICS Comments Off on Sedation in the Pediatric Intensive Care Unit: Challenges, Outcomes, and Future Strategies in the United States

1. Rule out treatable causes of agitation (a) Hypoxia and hypercarbia (b) Cerebral hypoperfusion (c) Bladder distention (d) Surgical lesion—necrotic bowel or compartment syndrome 2. Perform a presedation evaluation of the patient. This evaluation is similar…

read more

Incidence and Stratification of Adverse Events Associated with Sedation: Is There a Benchmark?

Nov 2, 2016 by in PEDIATRICS Comments Off on Incidence and Stratification of Adverse Events Associated with Sedation: Is There a Benchmark?

Adverse events Interventions performed in response 1. Oxygen desaturation • Vigorous tactile stimulation • Airway repositioning • Suctioning • Oral or nasal airway placement 2. Apnea: central versus obstructive (partial versus complete) • Administration of reversal agents…

read more

Sedation for Pediatric Gastrointestinal Procedures

Nov 2, 2016 by in PEDIATRICS Comments Off on Sedation for Pediatric Gastrointestinal Procedures

Sedation measures • Adverse events related to sedation • Adverse events related to procedure • Procedure completion rate • Procedure times • Patient recovery times • Patient satisfaction • Parent satisfaction • Provider satisfaction • Cost • Speed of recovery…

read more

Future of Pediatric Sedation

Nov 2, 2016 by in PEDIATRICS Comments Off on Future of Pediatric Sedation

New levels (as yet unnamed) Escalating risk of serious adverse event Physiological monitoring parameters (singular or combination)a Recommended sedationist skill set Recommended resourcesb 1 ≤1:10,000 Consistent with normal awake pattern…

read more

Pediatric Sedation: The European Experience and Approach

Nov 2, 2016 by in PEDIATRICS Comments Off on Pediatric Sedation: The European Experience and Approach

Reported practices Associated potentially serious consequences • Unmonitored PSA during magnetic resonance imaging (MRI) • Not discovering in time potentially dangerous side effects (respiratory depression, hypoxia or bradycardia) • No formal monitoring, observation,…

read more
Get Clinical Tree app for offline access